课题基金 / 基金详情

DOPAMINE TRANSPORTER-HUMAN & MOUSE GENES, DOPAMINERGIC DISORDERS & KNOCKO

DOPAMINE TRANSPORTER-HUMAN & MOUSE GENES, DOPAMINERGIC DISORDERS & KNOCKO
人类多巴胺转运蛋白
批准号:
6103870
负责人:
George Richard Uhl
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

George Richard Uhl的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The rewarding/reinforcing effects of cocaine have been thought to be produced, at least in part, by blocking reuptake of dopamine by the dopamine transporter (DAT). This is the site that accumulates each of the dopamine selective toxins that produce the best current experimental models for Parkinson's disease. The DAT gene is expressed in dopaminergic neurons of the ventral midbrain, and serves as the only currently-available marker expressed almost exclusively by these cells. During this FY, we completed sequencing of the human DAT gene, characterized each of the polymorphisms in its coding and several intronic regions, and examined the distributions of these polymorphisms in populations with drug abuse, ADHD, Tourette's syndrome, and several other phenotypes. We also completed mapping the patterns of linkage disequilibrium accross this locus. No clear coding region disease-related protein variant was identified. However, continued strengthening of association between the 3' untranslated region VNTR marker and ADHD in several studies spurs interest in regulatory region polymorphisms at this interesting locus.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PTPRD phosphatase inhibitors for stimulant use disorders
  • 批准号:
    10710969
  • 项目类别:
  • 资助金额:
    $38.63万
  • 财政年份:
    2022
  • 负责人:
    George Richard Uhl
  • 依托单位:
PTPRD phosphatase inhibitors for stimulant use disorders
  • 批准号:
    10653070
  • 项目类别:
  • 资助金额:
    $139.15万
  • 财政年份:
    2022
  • 负责人:
    George Richard Uhl
  • 依托单位:
PTPRD phosphatase inhibitors for stimulant use disorders
  • 批准号:
    10457132
  • 项目类别:
  • 资助金额:
    $145.39万
  • 财政年份:
    2022
  • 负责人:
    George Richard Uhl
  • 依托单位:
PTPRD ligands for stimulant and opiate use disorders
国内基金
海外基金
抗可卡因(Cocaine)抗体酶的研制及实验研究
  • 批准号:
    39570633
  • 项目类别:
    面上项目
  • 资助金额:
    8.5万元
  • 批准年份:
    1995
  • 负责人:
    段燕文
  • 依托单位: